Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
INTRODUCTION: Our study sought to characterize the presentation, local management and outcomes of invasive cervical cancer with regard to patient insurance status.
METHODS: We queried the NCI-SEER database for invasive cervical cancer cases in patients aged 18-64 from 2007 to 2011. We analyzed clinical and socioeconomic data with regard insurance status (insured, Medicaid, or uninsured). We tested for associations between patient insurance status and treatment with definitive surgery for FIGO IA2-IB1 patients, and treatment with suboptimal radiation therapy (RT) for FIGO IB2-IVA patients (other than combination external beam and brachytherapy). We evaluated overall and cause specific survival according to insurance status.
RESULTS: 11,714 cases were analyzed: 60% insured, 31% Medicaid, and 9% uninsured. FIGO III/IV stage at presentation was more frequent with Medicaid (40%) and uninsured (42%) compared to insured patients (28%) (p
CONCLUSIONS: Disparities in cervical cancer treatment with regard to insurance status are apparent in a recent cohort of American patients. Later stage at presentation and differences in management partially account for the inferior prognostic outcomes associated with Medicaid and uninsured status.
Published In/Presented At
Churilla, T., Egleston, B., Dong, Y., Shaikh, T., Murphy, C., Mantia-Smaldone, G., Chu, C., Rubin, S., & Anderson, P. (2016). Disparities in the management and outcome of cervical cancer in the United States according to health insurance status. Gynecologic oncology, 141(3), 516–523. https://doi.org/10.1016/j.ygyno.2016.03.025
Medicine and Health Sciences | Oncology
Department of Radiation Oncology